This particular variant is considered a risk variant for T1D and celiac disease (50, 51), and correlated with impaired IL-2 signalling in CD4+ T cells as measured by decreased phosphorylation of STAT5 (pSTAT5) but also reduced PTPN2 expression (52). This evidence concerns the gene IL2 and celiac disease.